Jeffrey J. Kimbell

Jeffrey J. Kimbell

Jeffrey J. Kimbell, President of Jeffrey J. Kimbell & Associates, represents 25 clients in the life sciences community seeking legislative and policy remedies in Washington. Founded in 1998, the ten person firm provides strategic solutions to hand-selected clients seeking creation, modification, or proper implementation of public law.

Mr. Kimbell has contributed to or been interviewed by a host of trade and global news publications and television programs including Bloomberg’s Business News, Time Magazine, The New York Times, Reuters, The Washington Post, The Bureau of National Affairs (BNA), Congressional Quarterly, Forbes, MX Magazine, Scripps-Howard, Roll Call, Politico, The Food & Drug Law Journal, and The Hill. Mr. Kimbell has testified before the U.S. Congress and spoken before numerous industry groups, boards of directors, scientific advisory boards, associations, and educational institutions, including Harvard, Georgetown and Stanford Business Schools, Columbia University School of Public Health, the Young Presidents’ Organization, AdvaMed, the OCTANe Medical Device & Investor Forum, AAOS Chicago Ophthalmology Summit, AECOS, and many others.

In January of 2001, Mr. Kimbell was named to President George W. Bush’s Transition Team Advisory Committee for the U.S. Department of Health and Human Services (HHS) and assisted a host of Presidential appointees through their confirmation process in the U.S. Senate. He was the only consultant to serve on the Committee.

Prior to establishing Kimbell & Associates, Mr. Kimbell served as the first Executive Director of the Medical Device Manufacturers Association (MDMA) from 1994-1998. While at MDMA, he directed all global policy initiatives on behalf of MDMA’s member companies. During his tenure, the association grew from 25 companies to 130, an increase that can be directly attributed to a number of legislative victories, including passage of a landmark bill to overhaul the product approval process at the U.S. Food & Drug Administration (FDA). In addition to handling matters before the U.S Congress, Mr. Kimbell was also responsible for MDMA’s interaction with state and foreign governments and federal agencies of jurisdiction on tax and trade matters.

Prior to serving at MDMA, Mr. Kimbell was a personal aide to former U.S. Senator Howard H. Baker, Jr. (R-TN) and personal attaché to former U.S. Secretary of State Lawrence S. Eagleburger in the Washington office of the Tennessee-based law firm Baker, Worthington, Crossley & Stansberry.

In addition to Jeffrey J. Kimbell & Associates, Mr. Kimbell is Managing Director of Jackalope Real Estate, LLC and Managing Partner of Magnum Entertainment Group, Inc. Jackalope is a real estate holding company with assets in Washington, DC, Park City, UT, and Cabo San Lucas, Mexico. Magnum is an entertainment company with over 85 corporate clients which produces live music events globally from Bangkok to Baltimore. Magnum events have featured artists including ZZ Top, Gregg Allman, Blues Traveler, Dickey Betts, Robert Earl Keen, and Better Than Ezra, among others.

A graduate of Southern Methodist University (SMU) in Dallas, TX, Mr. Kimbell earned his B.A. in Political Science. While at SMU, he worked for U.S. Congressman Sam Johnson (R-TX), a member of the House Ways & Means Committee, which has jurisdiction over tax, trade, and a significant portion of Medicare.

Mr. Kimbell is an At Large Board Member of Safari Club International, Vice President of the Safari Club International (SCI) Washington Metro Chapter and served as Chairman of the National SCI Political Action Committee (SCIPAC) from 2012-2014. Mr. Kimbell was elected President of the City Tavern Club of Washington from 2004-2007 and President of the Capital Club from 1997-1999. Mr. Kimbell currently serves on the Board of Trustees for St. George’s School in Newport, RI.

Mr. Kimbell, his wife Jessica, and their three children are avid sportsmen who enjoy fly fishing, hunting, and skiing at locales throughout the world when U.S. Congress is in recess.